1. Home
  2. AMLX

as 10-08-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Founded: 2014 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 749.9M IPO Year: 2022
Target Price: $15.14 AVG Volume (30 days): 2.0M
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.41 EPS Growth: N/A
52 Week Low/High: $2.60 - $15.14 Next Earning Date: 11-06-2025
Revenue: N/A Revenue Growth: -77.06%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AMLX Daily Stock ML Predictions

Stock Insider Trading Activity of Amylyx Pharmaceuticals Inc. (AMLX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Cohen Joshua B AMLX Co-Chief Executive Officer Sep 30 '25 Sell $14.67 29,933 $429,468.84 3,325,347
Mazzariello Gina AMLX Chief Legal Officer Sep 30 '25 Sell $14.58 8,828 $128,668.98 148,141
Klee Justin B. AMLX Co-Chief Executive Officer Sep 30 '25 Sell $14.69 29,975 $430,952.12 3,325,301
Bedrosian Camille L AMLX Chief Medical Officer Sep 30 '25 Sell $14.58 12,039 $175,517.78 182,336
FRATES JAMES M AMLX Chief Financial Officer Sep 30 '25 Sell $14.65 10,558 $154,650.42 280,430
Mazzariello Gina AMLX Chief Legal Officer Aug 13 '25 Sell $8.34 15,000 $125,046.00 148,141
Mazzariello Gina AMLX Chief Legal Officer Aug 12 '25 Sell $8.07 15,000 $121,102.50 148,141

Share on Social Networks: